FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for RosaceaEmrosi Initial Distribution Ongoing; First ...

BEIJING, CHINA / ACCESS Newswire / March 31, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here to read why PCRX stock is a Buy.

Annual Report/Annual ResultsAPONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out and merger planned 31.03.2025 / 14:00 CET/CESTThe issuer is solely ...

Q4 2024 Earnings Call Transcript March 20, 2025 Cognition Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Lisa Ricciardi; President, Chief Executive Officer, Director; Cognition Therapeutics Inc. John Doyle; Chief Fi ...

Q4 2024 Earnings Call Transcript March 24, 2025 Intellinetics, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.08. Operator: Greetings, and welcome to Intellinetics ...

Nearly a dozen voice actors interviewed by The Times said voice replication technology is reducing paid job opportunities and ...

Risk Factors and Management's Discussion and Analysis of Financial Conditions and Results of Operations in our annual report on Form 10-K filed earlier today. Also, please note that on the call ...

The Arlington County Board has restricted access to WERA 96.7's radio broadcast equipment and is wary of providing more ...

NEW YORK, NY / ACCESS Newswire / March 10, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to ...